The new maps from AIDSVu show more than 77,000 people were prescribed PrEP in 2016, with an average 73 percent increase year over year in persons using PrEP across the U.S. from 2012.
The Usual Suspects: Common Challenges for End the Epidemic Planning and Implementation in Emerging Jurisdictions
Leaders and experts in End the Epidemic planning processes share their perspectives on some of the most common roadblocks.
Due to community pressure and activism, the language that physicians, scientists, and public health bodies use to describe the potential for HIV transmission when a person has an undetectable viral load is now much clearer.
Presentations on women in research at this year's Conference on Retroviruses and Opportunistic Infections highlighted the lack of inclusion, offered ideas on how to remedy the situation, and showed how one woman moved from advocate to researcher.
Three video interviews with federal HIV leaders who shared perspectives about the science coming out of the conference and its implications for HIV prevention, care, and treatment.
2017 could have been worse. Although propelled to power by blustery threats to cut or eliminate publicly funded programs, including those that keep people living with HIV alive and well, the new administration has largely been unable to convert rheto...
The noted HIV researcher reflects on recent advances, the search for a cure, and the long road ahead.
Sanjabi talks about her early interest in science, her innovative research toward an HIV cure, and the importance of mentoring early career investigators.
"The stigma, fear and ignorance associated with HIV are still very strong; those of us who do this work on a daily basis might forget this sad fact," Paul Sax, M.D., writes.
"Nationally, we've seen only modest progress in retaining people in HIV care. The amount of improvement hasn't been enough."